Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon H Chung

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Oncotarget|December 26, 2013
A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesisJon H Chung, Fred Bunz
Plos Genetics|March 3, 2010
Cdk2 is required for p53-independent G2/M checkpoint controlJon H Chung, Fred Bunz
Cell Cycle (Georgetown, Tex.)|May 28, 2010
Checkpoint bypass and cell viabilityJon H Chung, Yonggang Zhang, Fred Bunz
Cell Cycle (Georgetown, Tex.)|March 22, 2012
Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cellsDeborah Wilsker, Jon H Chung, Fred Bunz
The Journal of Biological Chemistry|October 10, 2014
A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signalingJon H Chung, Andrew R Larsen, Evan Chen, et al.
Molecular Cancer Therapeutics|November 16, 2011
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalDeborah Wilsker, Jon H Chung, Ivan Pradilla, et al.
JCO Precision Oncology|February 17, 2022
Exceptional Response to Palbociclib in Metastatic Collecting Duct Carcinoma Bearing a <i>CDKN2A</i> Homozygous DeletionSumanta K Pal, Siraj M Ali, Jeffrey Ross, et al.
Clinical Genitourinary Cancer|December 29, 2019
Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic ProfilingNazli Dizman, Meghan Salgia, Siraj M Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2018
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failureAndrea Necchi, Daniele Raggi, Patrizia Giannatempo, et al.
Case Reports in Oncology|June 14, 2016
A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer PatientSiraj M Ali, Jessica Watson, Kai Wang, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Oncotarget|December 26, 2013
A loss-of-function mutation in PTCH1 suggests a role for autocrine hedgehog signaling in colorectal tumorigenesisJon H Chung, Fred Bunz
Plos Genetics|March 3, 2010
Cdk2 is required for p53-independent G2/M checkpoint controlJon H Chung, Fred Bunz
Cell Cycle (Georgetown, Tex.)|May 28, 2010
Checkpoint bypass and cell viabilityJon H Chung, Yonggang Zhang, Fred Bunz
Cell Cycle (Georgetown, Tex.)|March 22, 2012
Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cellsDeborah Wilsker, Jon H Chung, Fred Bunz
The Journal of Biological Chemistry|October 10, 2014
A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signalingJon H Chung, Andrew R Larsen, Evan Chen, et al.
Molecular Cancer Therapeutics|November 16, 2011
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalDeborah Wilsker, Jon H Chung, Ivan Pradilla, et al.
JCO Precision Oncology|February 17, 2022
Exceptional Response to Palbociclib in Metastatic Collecting Duct Carcinoma Bearing a <i>CDKN2A</i> Homozygous DeletionSumanta K Pal, Siraj M Ali, Jeffrey Ross, et al.
Clinical Genitourinary Cancer|December 29, 2019
Squamous Transformation of Prostate Adenocarcinoma: A Report of Two Cases With Genomic ProfilingNazli Dizman, Meghan Salgia, Siraj M Ali, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2018
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failureAndrea Necchi, Daniele Raggi, Patrizia Giannatempo, et al.
Case Reports in Oncology|June 14, 2016
A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer PatientSiraj M Ali, Jessica Watson, Kai Wang, et al.
Pageof 5